Effect of Growth Hormone (GH)-Releasing Hormone (GRH) on Plasma GH in Relation to Magnitude and Duration of GH Deficiency in 26 Children and Adults with Isolated GH Deficiency or Multiple Pituitary Hormone Deficiencies: Evidence for Hypothalamic GRH Deficiency*
Authors:
- 1 June 1984
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 58 (6) , 1043-1049
Abstract
Synthetic, amidated, 44 amino acid GH-releasing hormone (GRH-44) was administered iv at a dose of 5 µg/ kg to 20 patients with severe GH deficiency (GHD), 6 children and adolescents with partial GHD, and 6 non-GH deficient (NGHD) children and adolescents. The 17 patients with severe GHD that responded to GRH-44 had lower peak concentrations of plasma GH than the NGHD individuals (5.0 ± 1.2 (SEM) vs. 27.2 ± 3.5 ng/ ml; P < 0.0001). The children and adolescents with severe GHD tended to have higher peak GH responses to GRH-44 than the GHD adults (6.9 ± 1.7 vs. 2.4 ± 0.3 ng/ ml)although the difference was not significant. The peak GH concentration was attained earlier in the GHD children and adolescents than in the GHD adults (28 ± 4.7 vs. 69.3 ± 13 min, P < 0.004). There was a negative correlation between chronological age and peak plasma GH response to GRH in the children and adolescents with severe GHD (r = −0.758, P < 0.02). Children and adolescents with partial GHD had a higher mean peak concentration of plasma GH (13. 1 ± 1.8 ng/ ml) than the children, adolescents, and adults with severe GHD (P < 0.04), but one lower than the NGHD children and adolescents (P < 0.05). In both severe and partial GHD the GH response to GRH was greater thanthat elicited by standard pharmacological tests. Serum somatomedin-C did not increase after a single pulse of GRH-44 in the 12 GHD patients studied. PRL increased minimally 30 min after 5 µg/ kg iv GRH-44 in patients with multiple hypothalamic-pituitary hormone deficiencies but not in patients with isolated GHD or in NGHD individuals. The GH responses to GRH suggest that the majority of patients with isolated GHD as wellas those with multiple hypothalamic-pituitary hormone deficiencies have deficiency of hypothalamic GRH. Lack of a GH response to a single pulse of GRH does not exclude GRH deficiency as priming of the somatotrope with multiple pulses of GRH may be necessary to rule out a hypothalamic defect in the nonresponders. The results of this study support the potential usefulnessof GRH or its analogs in the diagnosis and treatment of selected patients with disorders of GH secretion.Keywords
This publication has 9 references indexed in Scilit:
- Corticotropin-Releasing Factor Test in Normal Subjects and Patients with Hypothalamic-Pituitary-Adrenal Disorders*The Journal of Clinical Endocrinology & Metabolism, 1983
- Human hypothalamic growth hormone releasing factor (GRF): Evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40Biochemical and Biophysical Research Communications, 1983
- EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCYThe Lancet, 1983
- Abnormalities of growth hormone release in response to human pancreatic growth hormone releasing factor (GRF (1-44) ) in acromegaly and hypopituitarism.BMJ, 1983
- SOMATOCRININ INDUCES RELEASE OF GROWTH-HORMONE IN ONE CASE OF GROWTH-HORMONE DEFICIENCY OF HYPOTHALAMIC ORIGIN1983
- HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MANThe Lancet, 1983
- Induction of Puberty in Men by Long-Term Pulsatile Administration of Low-Dose Gonadotropin-Releasing HormoneNew England Journal of Medicine, 1982
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused AcromegalyScience, 1982
- Effects of CNS Active Drugs and Somatostatin Antiserum on Growth Hormone Release in Young and Old Male RatsNeuroendocrinology, 1981